Game-changing Cancer treatment: A new precision Radiotherapy cuts prostate Cancer sessions from 20 to just five

Cancer treatments and the endless number of sessions often make it difficult for the patients to heal from the pain. Recently, a game-changing discovery is expected to change the condition of thousands of men in England who have been struggling with Prostate Cancer, as a new technology is about to reduce the number of sessions to just five. Here’s all you need to know about these precision-driven radiotherapy sessions. How will precision therapy change the course of treatment?As per a report published in the digital daily, BBC it was mentioned that these men in England will now be able to go for the high-powered, precision radiotherapy that slashes their treatment sessions from 20 down to just five. This new technique is known as Stereotactic Ablative Radiotherapy (SABR). As per the report, this technique targets the disease far more effectively than standard options while cutting down on harsh side effects. However, this technology is already used for lung and brain cancers; this marks the first time SABR will be offered to low- and intermediate-risk prostate cancer patients outside of clinical trials.The shocking statisticsAbout 55,000 men are diagnosed with prostate cancer every year, and around 17,500 of them fall into the low- or intermediate-risk categories. Experts model that about a fifth of these men—roughly 3,500 patients—will choose this new radiotherapy. However, rest of the people often choose "active monitoring" instead of immediate treatment, since low-risk prostate cancers grow incredibly slowly and may never actually cause harm. NHS England expects all 48 of the country's radiotherapy centers to begin offering the five-session treatment within weeks.According to Prof Peter Johnson, the National Clinical Director for Cancer, it was found that while the rollout won't benefit every single prostate cancer patient, it is a massive step forward. "This technology lets us focus a powerful and precise beam of radiotherapy directly on to the cancer, limiting the damage to healthy cells," he said. "And the fact it can be delivered in 15 fewer doses will help men get back to living their lives far more quickly."Moreover, charities are equally optimistic about the rollout. Amy Rylance from Prostate Cancer UK called it "wonderful news that thousands of men in England will now have access to this revolutionary targeted radiotherapy." She added that it will "massively reduce the burden that cancer places on them, and their loved ones," noting the charity hopes the treatment will expand to even more patients down the road.While the current rollout focuses on lower-risk cases, trials are already underway to see if SABR can safely treat high-risk prostate cancer patients too.The trail sessionsOne trial participant, 70-year-old Edwin Lambert from Suffolk, was diagnosed in January 2025. He started on hormone therapy first, which left him dealing with tough side effects like hot flushes, mood swings, fatigue, and a loss of libido. When he switched to the new precision radiotherapy targeting his prostate and lymph nodes, he found it much easier to handle. Lambert recalled seeing men undergoing traditional radiotherapy in the hospital who looked "dreadful" compared to him because of their repeated, drawn-out treatments. Though he experienced a temporary need to urinate more frequently during and just after his sessions, he recovered quickly. Within five weeks, he was back on his feet and participating in an archaeological dig he had been planning for a long time. "This treatment was an absolute godsend," he said.What are your thoughts on this advanced technology?